Checkpoint Therapeutics Inc.https://investorshangout.com/Checkpoint-Therapeutics-Inc-CKPT-93848/en-usThu, 03 Sep 2026 06:53:21 GMTCopyright InvestorsHangout.comdocj: Reiterates HC Wainwright & Co.: Buy to Buy 12/19/2023 $34 price targethttps://investorshangout.com/post/view?id=6655579https://investorshangout.com/post/view?id=6655579Wed, 20 Dec 2023 10:39:20 GMTdocj: B Riley cut price target from $8 to $4https://investorshangout.com/post/view?id=6655578https://investorshangout.com/post/view?id=6655578Wed, 20 Dec 2023 10:36:50 GMTdocj: From CKPT: U.S. Food and Drug Administration Issues Complete Response Letter for Cosibelimab Solehttps://investorshangout.com/post/view?id=6655538https://investorshangout.com/post/view?id=6655538Wed, 20 Dec 2023 02:15:11 GMTdocj: UPDATE 1-US FDA declines to approve Checkpoint Therapeutics' skin cancer therapy 1 Mon, December 1https://investorshangout.com/post/view?id=6655537https://investorshangout.com/post/view?id=6655537Wed, 20 Dec 2023 02:11:23 GMTznewcar1: CKPT 17% v2,1M c3.18 f67,8M H3.26 S3https://investorshangout.com/post/view?id=6016668https://investorshangout.com/post/view?id=6016668Tue, 12 Jan 2021 21:26:11 GMTznewcar1: CKPT 19% v5,3M c3.91 f60,0M H4.32 S3.75https://investorshangout.com/post/view?id=5894945https://investorshangout.com/post/view?id=5894945Tue, 15 Sep 2020 20:39:50 GMT